HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)
Clinical trials for HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS) explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS) trials appear
Sign up with your email to follow new studies for HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Not yet recruitingThis early-stage trial tests a new treatment for people with acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS) that have come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to target a protein …
Matched conditions: HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 26, 2026 05:21 UTC
-
Leukemia biobank aims to unlock secrets of blood cancers
Knowledge-focused Not yet recruitingThis study will collect extra blood and bone marrow samples from 1,000 adults with acute myeloid leukemia, acute lymphoid leukemia, or high-risk myelodysplastic syndrome. The samples will be used by researchers to better understand these diseases and find new ways to diagnose and…
Matched conditions: HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC